Phase II Research Study of Arsenic Trioxide (Trisenox) in Patients With Myelodysplastic Syndrome (MDS)

This study has been terminated.

( terminated due to lack of accrual. )

Study NCT00225992 Information provided by Oncology Specialties, Alabama

First Received: September 22, 2005 Last Updated: April 18, 2007 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given